Biocept, Inc.
BIOCQ · OTC
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $418 | $1,997 | $2,999 | $5,218 |
| - Cash | $6,633 | $6,774 | $12,897 | $18,021 |
| + Debt | $11,591 | $11,583 | $12,109 | $12,262 |
| Enterprise Value | $5,376 | $6,806 | $2,211 | -$541 |
| Revenue | $589 | $673 | -$10,285 | $1,007 |
| % Growth | -12.5% | 106.5% | -1,121.4% | – |
| Gross Profit | -$1,961 | -$2,355 | -$14,592 | -$4,769 |
| % Margin | -332.9% | -349.9% | 141.9% | -473.6% |
| EBITDA | -$2,915 | -$6,484 | -$18,162 | -$9,532 |
| % Margin | -494.9% | -963.4% | 176.6% | -946.6% |
| Net Income | -$3,631 | -$7,144 | -$18,522 | -$10,125 |
| % Margin | -616.5% | -1,061.5% | 180.1% | -1,005.5% |
| EPS Diluted | -3.5 | -12.16 | -32.732 | -17.87 |
| % Growth | 71.2% | 62.9% | -83.2% | – |
| Operating Cash Flow | -$3,086 | -$6,194 | -$4,242 | -$4,076 |
| Capital Expenditures | -$97 | -$91 | -$136 | -$356 |
| Free Cash Flow | -$3,183 | -$6,285 | -$4,378 | -$4,432 |